Narcotic antagonist therapy of the obesity hypoventilation syndrome

Crit Care Med. 1982 Sep;10(9):604-7. doi: 10.1097/00003246-198209000-00010.

Abstract

A child with respiratory failure and cor pulmonale secondary to the obesity hypoventilation syndrome (OHS) was found to have abnormal beta-endorphin levels in cerebrospinal fluid (CSF) and serum. A single iv dose of 10 microgram/kg of naloxone early in the course of respiratory failure resulted in dramatic improvement which lasted approximately 3 to 4 h. The patient failed to response to progesterone, and because of deteriorating respiratory status a low-dose continuous infusion of naloxone, 2 microgram/kg.h, was begun and gradually increased to 10 microgram/kg.h, during which time there was a dramatic improvement in respiratory status and clinical condition. After 5 days, naloxone infusion was discontinued and progressive respiratory deterioration recurred. The child died of over-whelming sepsis and disseminated intravascular coagulation.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Carbon Dioxide
  • Endorphins / blood
  • Endorphins / cerebrospinal fluid
  • Female
  • Humans
  • Infant
  • Male
  • Naloxone / therapeutic use*
  • Obesity Hypoventilation Syndrome / drug therapy
  • Obesity Hypoventilation Syndrome / genetics
  • Obesity Hypoventilation Syndrome / physiopathology*
  • Pulmonary Heart Disease / etiology
  • Respiratory Insufficiency / etiology
  • beta-Endorphin

Substances

  • Endorphins
  • Carbon Dioxide
  • Naloxone
  • beta-Endorphin